Read Larry Connors' blog – Short Term Trading Strategies
The partners will jointly evaluate ways to improve Grameen Health's existing healthcare delivery systems and primary care clinics in rural Bangladesh. In the next year, they will identify appropriate business models that ultimately can be replicated in other countries, addressing the needs of the 4 billion people around the world whose annual income is less than $3,000. As part of its commitment to the collaboration, GE Healthcare will test delivery of ultrasound capability in rural clinics for early detection of abnormalities, especially in the context of maternal care.
"GE Healthcare is committed to early health initiatives," said Omar Ishrak, President & Chief Executive Officer, Clinical Systems, GE Healthcare. "We have affordable technology with advanced imaging and care capabilities that can make a difference to save lives. With the ubiquitous usage of ultrasound, GE believes it's provided a crucial tool in the early care of expectant mothers. We intend to work with Grameen Health to further understand and expand ultrasound usage in rural areas. Through this pilot program we plan to train providers in the usage of ultrasound, evaluate the product, the training and the workflow that would be needed to enable the full deployment of this technology. This is one positive step towards accessible and sustainable healthcare for the developing world."
GE noted that it has taken steps to enhance accessibility of ultrasound through training and education, starting with a pilot program with U.S.-based medical school students. Medical students participating in the pilot study also helped GE Healthcare to determine how medical students learn, to gather data from the 'new ultrasound user' in order to improve the design of the ultrasound equipment, and to determine whether the use of the ultrasound device during medical training will have beneficial effects on medical training itself. The ultrasound curriculum adds a hands-on component with immediate results that show students the practical applications of technology in medicine.
"Technologies such as ultrasound can be used to help detect diseases earlier, when they can be more effectively treated," said Dr. Bob Honigberg, Chief Medical Officer of GE Healthcare. "These pilot studies may provide support for more primary care physicians to utilize miniaturized ultrasound technology to supplement tools that are used today."
During the next year, the companies said the partnership will focus on the following areas:
- Primary health promotion and disease prevention, the most cost effective steps in affordable health care - Evaluate product, training, workflow, and other capabilities that would be needed for full deployment of ultrasound capability in rural areas - Developing continuous training programs for nurses, technicians and physicians in the usage of ultrasound - Reviewing operating efficiencies and scope of services (e.g., telemedicine, mobile health care) at Grameen Health's Kalyan clinics.
According to the World Health Organization, among the biggest obstacles to improved health outcomes are inadequate health delivery and financing mechanisms that place the heaviest burden on the poor and sick, who are the least able to pay.
In addition to its partnership with GE Healthcare, Grameen is partnering with Pfizer Inc., which will dedicate key employees to provide technical and advisory support to evaluate Grameen's existing healthcare delivery systems in Bangladesh. Grameen is also partnering with the Mayo Clinic, to improve the training, efficiency, and retention of staff at existing Grameen Health Kalyan clinics.
((Comments on this story may be sent to newsdesk@closeupmedia.com))
((Distributed via M2 Communications Ltd - http://www.m2.com))
http://www.10meters.com
Comments on this story may be sent to newsdesk@closeupmedia.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
